These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27327493)

  • 21. Intragenic deletion of UBE3A gene in 2 sisters with Angelman syndrome detected by MLPA.
    Piard J; Depienne C; Keren B; Fédirko E; Trouillard O; Charles P; Heron D
    Am J Med Genet A; 2011 Dec; 155A(12):3170-3. PubMed ID: 22065487
    [No Abstract]   [Full Text] [Related]  

  • 22. Atypical absences and recurrent absence status in an adult with Angelman syndrome due to the UBE3A mutation.
    Espay AJ; Andrade DM; Wennberg RA; Lang AE
    Epileptic Disord; 2005 Sep; 7(3):227-30. PubMed ID: 16162432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodevelopmental profile of siblings with Angelman syndrome due to pathogenic UBE3A variants.
    Sadhwani A; Willen JM; Miller H; Barbieri-Welge R; Horowitz LT; Noll LM; Peters S; Hundley R; Bird LM; Tan WH
    J Intellect Disabil Res; 2020 Mar; 64(3):246-250. PubMed ID: 31854050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue.
    Ray B; Sokol DK; Maloney B; Lahiri DK
    Sci Rep; 2016 May; 6():26052. PubMed ID: 27212113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Angelman syndrome: clinical and genetic model].
    Dan B; Chéron G
    Rev Neurol (Paris); 2003 May; 159(5 Pt 1):499-510. PubMed ID: 12773895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapies in preclinical and clinical development for Angelman syndrome.
    Markati T; Duis J; Servais L
    Expert Opin Investig Drugs; 2021 Jul; 30(7):709-720. PubMed ID: 34112038
    [No Abstract]   [Full Text] [Related]  

  • 27. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
    Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
    J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UBE3A gene mutations in Finnish Angelman syndrome patients detected by conformation sensitive gel electrophoresis.
    Rapakko K; Kokkonen H; Leisti J
    Am J Med Genet A; 2004 Apr; 126A(3):248-52. PubMed ID: 15054837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations.
    Mertz LG; Thaulov P; Trillingsgaard A; Christensen R; Vogel I; Hertz JM; Ostergaard JR
    Res Dev Disabil; 2014 Jul; 35(7):1742-7. PubMed ID: 24656292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
    Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
    Mol Autism; 2018; 9():47. PubMed ID: 30220990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation Update for UBE3A variants in Angelman syndrome.
    Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
    Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of genetic polymorphism analysis for the diagnosis of Angelman syndrome and the correlation between language difficulties and disease phenotype.
    Wang K; Li YT; Hou M
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal treatment path for angelman syndrome and other neurodevelopmental disorders.
    Zylka MJ
    Autism Res; 2020 Jan; 13(1):11-17. PubMed ID: 31490639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
    Chaudhary P; Proulx J; Park IW
    Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.
    Pandya NJ; Wang C; Costa V; Lopatta P; Meier S; Zampeta FI; Punt AM; Mientjes E; Grossen P; Distler T; Tzouros M; Martí Y; Banfai B; Patsch C; Rasmussen S; Hoener M; Berrera M; Kremer T; Dunkley T; Ebeling M; Distel B; Elgersma Y; Jagasia R
    Cell Rep Med; 2021 Aug; 2(8):100360. PubMed ID: 34467244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From electrophysiology to chromatin: a bottom-up approach to Angelman syndrome.
    Dan B; Servais L; Boyd SG; Wagstaff J; Cheron G
    Ann N Y Acad Sci; 2004 Dec; 1030():599-611. PubMed ID: 15659843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant transcriptional changes in 15q duplication but not Angelman syndrome deletion stem cell-derived neurons.
    Urraca N; Hope K; Victor AK; Belgard TG; Memon R; Goorha S; Valdez C; Tran QT; Sanchez S; Ramirez J; Donaldson M; Bridges D; Reiter LT
    Mol Autism; 2018; 9():6. PubMed ID: 29423132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.
    Sutcliffe JS; Jiang YH; Galijaard RJ; Matsuura T; Fang P; Kubota T; Christian SL; Bressler J; Cattanach B; Ledbetter DH; Beaudet AL
    Genome Res; 1997 Apr; 7(4):368-77. PubMed ID: 9110176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Angelman syndrome--from the phenotype of a developmental disorder to the genes].
    Holopainen IE; Kokkonen H; Korpi ER
    Duodecim; 2001; 117(4):383-7. PubMed ID: 12092380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.